The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents.
C. Mathieu, and L. Adorini. Trends in molecular medicine, 8 (4):
174--179(April 2002)
Abstract
The active form of vitamin D, 1,25-dihydroxyvitamin D(3)1,25(OH)(2)D(3), is a secosteroid hormone that regulates calcium and bone metabolism, controls cell proliferation and differentiation, and exerts immunoregulatory activities. This range of functions has been exploited clinically to treat a variety of conditions, from secondary hyperparathyroidism to osteoporosis, to autoimmune diseases such as psoriasis. Recent advances in understanding 1,25(OH)(2)D(3) functions and novel insights into the mechanisms of its immunomodulatory properties suggest a wider applicability of this hormone in the treatment of autoimmune diseases and allograft rejection.
%0 Journal Article
%1 citeulike:9976301
%A Mathieu, Chantal
%A Adorini, Luciano
%D 2002
%J Trends in molecular medicine
%K vitamind
%N 4
%P 174--179
%T The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents.
%U http://view.ncbi.nlm.nih.gov/pubmed/11927275
%V 8
%X The active form of vitamin D, 1,25-dihydroxyvitamin D(3)1,25(OH)(2)D(3), is a secosteroid hormone that regulates calcium and bone metabolism, controls cell proliferation and differentiation, and exerts immunoregulatory activities. This range of functions has been exploited clinically to treat a variety of conditions, from secondary hyperparathyroidism to osteoporosis, to autoimmune diseases such as psoriasis. Recent advances in understanding 1,25(OH)(2)D(3) functions and novel insights into the mechanisms of its immunomodulatory properties suggest a wider applicability of this hormone in the treatment of autoimmune diseases and allograft rejection.
@article{citeulike:9976301,
abstract = {{The active form of vitamin D, 1,25-dihydroxyvitamin D(3)[1,25(OH)(2)D(3)], is a secosteroid hormone that regulates calcium and bone metabolism, controls cell proliferation and differentiation, and exerts immunoregulatory activities. This range of functions has been exploited clinically to treat a variety of conditions, from secondary hyperparathyroidism to osteoporosis, to autoimmune diseases such as psoriasis. Recent advances in understanding 1,25(OH)(2)D(3) functions and novel insights into the mechanisms of its immunomodulatory properties suggest a wider applicability of this hormone in the treatment of autoimmune diseases and allograft rejection.}},
added-at = {2011-11-04T06:39:59.000+0100},
author = {Mathieu, Chantal and Adorini, Luciano},
biburl = {https://www.bibsonomy.org/bibtex/23f22ce6e93d45cdd8fc6ec7de69710e7/alimuzaffar},
citeulike-article-id = {9976301},
citeulike-linkout-0 = {http://view.ncbi.nlm.nih.gov/pubmed/11927275},
citeulike-linkout-1 = {http://www.hubmed.org/display.cgi?uids=11927275},
interhash = {22bb71c7fc3603ad89bcfca4fd7f8876},
intrahash = {3f22ce6e93d45cdd8fc6ec7de69710e7},
issn = {1471-4914},
journal = {Trends in molecular medicine},
keywords = {vitamind},
month = apr,
number = 4,
pages = {174--179},
pmid = {11927275},
posted-at = {2011-11-01 17:57:02},
priority = {2},
timestamp = {2011-11-04T06:39:59.000+0100},
title = {{The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents.}},
url = {http://view.ncbi.nlm.nih.gov/pubmed/11927275},
volume = 8,
year = 2002
}